AAM Questions FDA’s Product Identifiers in Supply Chain Guidance By Sam | December 3, 2018 Generic drugmakers urged the FDA to allow for more flexibility in draft guidance on product identifiers under the Drug Supply Chain Security Act (DSCSA). Source: Drug GMP Report Posted in Drug GMP Report